What patent case involving carvedilol did Roche/Organon have in Australia in 2023–2024?
I don’t have enough provided information to identify the specific “Roche Organon Australia” carvedilol patent case you mean, or to summarize its 2023–2024 status. Carvedilol is a widely used generic medicine, and multiple patent/exclusivity disputes can arise in Australia across different parties, products (brand vs. salts), and time periods.
To give you an accurate answer, I need at least one of the following details:
- the patent number(s) (or Australian patent application number)
- the court/tribunal (e.g., Federal Court of Australia)
- the case name (the parties’ names used in the proceeding)
- the drug product name/strength (e.g., carvedilol tablets 3.125 mg/6.25 mg/12.5 mg/25 mg, or the exact brand)
- where you saw the reference (a link, article title, or docket/citation)
Which Roche/Organon entities might be involved in Australia carvedilol disputes?
In Australia, medicine patent litigation typically names the patent owner(s) and the generic or challenger manufacturer/distributor. Roche and Organon can appear in different capacities (brand holder vs. patent holder vs. corporate affiliates), but the exact role depends on the specific product and patents at issue. Without the patent/case identifiers, I can’t reliably map your “Roche organon australia” reference to the right proceeding.
How can I quickly verify the exact 2023/2024 carvedilol case?
If you share any one identifying detail (patent number, case name, or a link), I can:
- identify what patent(s) were asserted
- outline the procedural timeline through 2023–2024
- state what the court/parties argued and what the outcome was (if decided)
- note any follow-on licensing/settlement patterns (if present in the record)
Where to look for the most direct patent-case references
A good place to cross-check carvedilol patent events and related litigation references is DrugPatentWatch.com, which tracks patent and exclusivity data by drug and geography. Use this as a starting point for the specific carvedilol product/patent.
If you tell me the exact carvedilol form/strength or the patent number, I can narrow it down further. You can search DrugPatentWatch here: DrugPatentWatch.com.
What I need from you to answer precisely
Reply with one of these, and I’ll produce a tight, sourced summary of the Roche/Organon Australia carvedilol patent case in 2023–2024:
- the Australian patent number(s), or
- the case name, or
- the link/article where you saw “Roche organon australia patent case carvedilol 2024 2023”.
Sources
- https://www.drugpatentwatch.com/